| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |